Fastenal Company

Fastenal’s latest 10-Q offers a specific caution to those attempting to reconcile its reported figures. The MD&A, Item 7, notes that percentages, values, and dollar change calculations… may not be able to be recalculated or footed due to rounding. Footing, the process of verifying that column totals or cross-calculations add up correctly, is a fundamental step in financial statement analysis. This explicit disclosure suggests a potential hurdle for detailed quantitative review, as the underlying unrounded figures are not presented. Furthermore, all historical share information has been retroactively adjusted for a May 2025 two-for-one stock split, requiring careful attention to comparability.

While the filing provides financial data, the forensic accounting metrics are not available for this reading. Beneish’s M-Score, a 1999 eight-ratio earnings-manipulation detector, would typically flag elevated risk above -1.78. Altman’s Z″, a 1968 bankruptcy-distress index, categorizes companies into distress (<1.10), grey (1.10–2.60), or safe (>2.60) zones. Piotroski’s F-Score, a 9-point fundamental strength scan, gauges a company’s financial health, with scores below 4 indicating weakness. Lastly, the Fog Index, a readability score where 12 is newspaper-level and 18+ is obfuscatory, helps assess disclosure clarity. The absence of these calculated scores limits a quick quantitative assessment of potential accounting anomalies or financial stress.

Beyond the general caveats, Item 7 also highlights the retroactively adjusted to reflect the two-for-one stock split effective May 21, 2025. Such adjustments are standard practice for comparability but require analysts to ensure their models account for the change. Separately, the balance sheet in Item 1A reveals trade accounts receivable, net of allowance for credit losses, increased from $1,245.3 million at December 31, 2025, to $1,445.2 million at March 31, 2026. This 16% increase in receivables over a quarter, while not inherently problematic, warrants consideration in conjunction with sales figures to assess collection efficiency, especially given the MD&A’s mention of “daily sales rate (DSR) change.”

This reading, constrained by the provided excerpts and the absence of computed forensic scores, offers a limited view of Fastenal’s financial position. The filing itself provides specific instructions on how to interpret its figures, particularly regarding the stock split and the rounding of dollar values. It does not, however, offer insights into the broader market’s perception of the company, nor does it project future performance or operational challenges beyond what is explicitly stated in the MD&A. A comprehensive assessment would require a full review of the financial statements and notes, alongside a detailed calculation of the aforementioned forensic metrics.